Patricia Habimana, MD
Pain Medicine · New Albany, INNPI 1386848455
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 49.2% of the total. Reporting peaked in 2024 at $2,435 and has fallen 87.7% since, to $300 in 2025.
Across 58 payments — averaging $72.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$2K
- Medtronic$722
- Abbott$680
- Boston Scientific$185
- Stimwave Technologies Incorporated$109
- Nevro Corp.$108
- plus $339 from 9 others
What the payments were for
- Travel & lodging$1,71941%
- Food & beverage$2,50259%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 8 | $2,078 |
| Medtronic(2 entities) | 9 | $722 |
| Abbott | 14 | $680 |
| Boston Scientific | 9 | $185 |
| Stimwave Technologies Incorporated | 1 | $109 |
| Nevro Corp. | 2 | $108 |
| SPR Therapeutics, Inc | 1 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Vertex | 2 | $43 |
| Pacira Therapeutics, Inc. | 3 | $43 |
| Globus Medical | 2 | $38 |
| Avanos Medical | 1 | $30 |
| Si-bone, Inc. | 1 | $17 |
| Biotronik NRO, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$1,962
- ASCENDA$368
- SYNCHROMED$150
- PROCLAIM$144
- Proclaim IPG$120
How this compares
$4,221 in reported general payments places this provider in the 55th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,427 | $28,690 |
| LyricaPregabalin | 12 | $14,281 |
| ZtlidoLidocaine | 13 | $11,425 |
| Lidocaine | 73 | $11,252 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 443 | $10,355 |
| Gabapentin | 837 | $10,238 |
| Buprenorphine | 27 | $7,295 |
| Pregabalin | 231 | $6,535 |
| Morphine Sulfate ErMorphine Sulfate | 179 | $5,322 |
| Oxycodone Hcl | 210 | $4,435 |
| Tizanidine Hcl | 291 | $2,342 |
| Tramadol Hcl | 239 | $1,960 |
| Lubiprostone | 19 | $1,588 |
| Methocarbamol | 167 | $1,129 |
| Cyclobenzaprine Hcl | 132 | $1,077 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in New Albany
- Nirav PatelNew Albany$7K
- Derron WilsonCarmel$616K
- Kevin MacadaegCarmel$337K
- Andrew TrobridgeMuncie$253K
- Meredith LanghorstFishers$233K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
- John SwoffordIndianapolis$127K
- Neal ColemanMuncie$38K
- Matthew DevriesLafayette$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.